None of us likes being down here at 10c. The last CR was a surprise but I think that was magnified because many would have expected we'd already know whether a deal would be done on the back of amazing 1103 results. Well we didn't get the clear cut results we were hoping for because we needed testing at the higher dose. So what did management do? They tapped the market for enough funds to get through the additional 600mg testing, which I was very happy to see they have already submitted for approval.
Could we have been dudded on this raise? Maybe, some events seem to fit that scenario. But if you squint with the other eye it can also look like everything was innocent.
Either way I still believe management wants to get a deal done as asap.
ANP Price at posting:
10.7¢ Sentiment: Buy Disclosure: Held
